AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Collegium Pharmaceutical, Inc. Common Stock
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001T535S9
22.96▼ 0.54 (-2.30%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
23.50
Day's Range
22.15 – 23.49
52-Week Range
21.43 – 50.79
Volume
662.4K
Avg Volume
797.9K
Share Statistics
Shares Outstanding
Employees
423
Exchange
XNAS
Listed
2015-05-07
Share count as of July 31, 2026

Collegium Pharmaceutical, Inc. Common Stock (COLL) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Collegium Pharmaceutical, Inc. Common Stock (COLL)
What is Collegium Pharmaceutical, Inc. Common Stock's Market Cap?
Collegium Pharmaceutical, Inc. Common Stock's Market Cap is $747.5M, based on as-reported figures from SEC (XBRL) filings.
What is Collegium Pharmaceutical, Inc. Common Stock's Enterprise Value?
Collegium Pharmaceutical, Inc. Common Stock's Enterprise Value is $618.0M, based on as-reported figures from SEC (XBRL) filings.
What is Collegium Pharmaceutical, Inc. Common Stock's Trailing P/E?
Collegium Pharmaceutical, Inc. Common Stock's Trailing P/E is 15.6×, based on as-reported figures from SEC (XBRL) filings.
What is Collegium Pharmaceutical, Inc. Common Stock's Price / Sales?
Collegium Pharmaceutical, Inc. Common Stock's Price / Sales is 0.9×, based on as-reported figures from SEC (XBRL) filings.
What is Collegium Pharmaceutical, Inc. Common Stock's EV / Revenue?
Collegium Pharmaceutical, Inc. Common Stock's EV / Revenue is 0.8×, based on as-reported figures from SEC (XBRL) filings.
What is Collegium Pharmaceutical, Inc. Common Stock's EV / EBITDA?
Collegium Pharmaceutical, Inc. Common Stock's EV / EBITDA is 1.6×, based on as-reported figures from SEC (XBRL) filings.
What is Collegium Pharmaceutical, Inc. Common Stock's Revenue (TTM)?
Collegium Pharmaceutical, Inc. Common Stock's Revenue (TTM) is $808.2M, based on as-reported figures from SEC (XBRL) filings.
What is Collegium Pharmaceutical, Inc. Common Stock's Net Income (TTM)?
Collegium Pharmaceutical, Inc. Common Stock's Net Income (TTM) is $47.9M, based on as-reported figures from SEC (XBRL) filings.
What is Collegium Pharmaceutical, Inc. Common Stock's EBITDA?
Collegium Pharmaceutical, Inc. Common Stock's EBITDA is $391.0M, based on as-reported figures from SEC (XBRL) filings.
What is Collegium Pharmaceutical, Inc. Common Stock's Diluted EPS (TTM)?
Collegium Pharmaceutical, Inc. Common Stock's Diluted EPS (TTM) is 1.47, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · COLLAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Product revenues, net
YoY growth+6.3%+8.9%+12.9%+31.4%
Cost of product revenues
Cost of product revenues (excluding intangible asset amortization)
Intangible asset amortization——
Total cost of product revenues
Gross profit
% of revenue55.2%60.6%62.5%61.7%
Operating expenses
Selling, general and administrative
Gain on fair value remeasurement of contingent consideration
Total operating expenses
% of revenue53.3%44.6%32.9%32.0%
Income from operations
% of revenue1.9%16.0%29.6%29.7%
Interest expense
Interest income
(Loss) income before income taxes
Provision for income taxes
Net (loss) income
% of revenue-7.5%7.5%8.3%15.0%
(Loss) earnings per share — basic (in dollars per share)
(Loss) earnings per share — diluted (in dollars per share)—